Clinical Trial Update: Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke [Phase 2]

View source ↗

Summary

Phase 2 study of HC-58 in patients with severe upper limb hemiplegia after stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• HC-58

Snippet

Sponsor: Asahi Kasei Therapeutics Corporation | Conditions: Severe Upper Limb Hemiplegia | Phase 2 | Status: COMPLETED